Inactive Instrument

Onyx Pharmaceuticals, Inc. Stock

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2013	Gilead Sciences, Inc. : Bradway's patient dealmaking brings Onyx to Amgen	RE
2013	Onyx Pharmaceuticals, Inc. : Onyx deal expected to give Amgen a big boost	RE

Gilead Sciences, Inc. : Bradway's patient dealmaking brings Onyx to Amgen	13-08-26	RE
Onyx Pharmaceuticals, Inc. : Onyx deal expected to give Amgen a big boost	13-08-26	RE
Onyx Pharmaceuticals, Inc. : Onyx deal expected to give Amgen a big boost	13-08-26	RE
AstraZeneca plc : AstraZeneca to buy U.S. cancer firm for up to $500 million	13-08-26	RE
Pfizer Limited : Amgen close to buying Onyx for $125 per share: sources	13-08-24	RE
Amgen, Inc. : Exclusive: Onyx provides drug trial data to potential bidders - sources	13-08-21	RE
Onyx Pharmaceuticals, Inc. : Amgen seeks drug trial data before finalizing Onyx deal: sources	13-08-15	RE
Bank of America Corp : Amgen deal for Onyx possible within week - sources	13-08-07	RE
Bank of America Corp : Amgen deal for Onyx possible within week-sources	13-08-07	RE
Biogen Idec Inc : Exclusive: Pfizer not moving forward with Onyx bid: sources	13-07-18	RE
Ranbaxy Laboratories Limited : Novartis lifts full-year outlook after competition delay	13-07-17	RE
Pfizer Inc. : Roche seeks financing for potential Alexion bid -sources	13-07-12	RE
Insmed Incorporated : S&P 500 extends gains to year's second half on solid data	13-07-01	RE
Onyx Pharmaceuticals, Inc. : Pfizer, Novartis may join Amgen in bidding for Onyx: sources	13-07-01	RE
Onyx Pharmaceuticals, Inc. : Onyx explores possible sale after rejecting Amgen offer	13-06-30	RE

Onyx Pharmaceuticals : Amgen Receives CHMP Positive Opinions for Two New Treatment Options for Patients with Blood Cancer in Europe	15-10-01	PU
Onyx Pharmaceuticals : Amgen Submits Supplemental New Drug Application for Kyprolis® (Carflizomib) in Relapsed Multiple Myeloma	15-07-23	PU
Onyx Pharmaceuticals : Amgen Initiates Phase 3 Study Evaluating Once-Weekly Kyprolis® (Carflizomib) in Patients with Relapsed and Refractory Multiple Myeloma	15-05-31	PU
Onyx Pharmaceuticals : Amgen to Advance Understanding of the Treatment of Blood Cancers at the 20th Congress of European Hematology Association (EHA)	15-05-27	PU
Onyx Pharmaceuticals : Amgen Data at ASCO 2015 Highlight Oncology Pipeline and Portfolio	15-05-13	PU

Onyx Pharmaceuticals, Inc. : Les propos de Kerry sur la Syrie font trébucher Wall St	13-08-26
Les valeurs à suivre aujourd'hui à Wall Street	13-08-26
Amgen, Inc. : s'offre le groupe pharmaceutique ONYX pour 10,4 milliards de dollars	13-08-26
Amgen sur le point de racheter Onyx	13-08-25
Onyx Pharmaceuticals, Inc. : Exclusif-Onyx fournit des données cliniques à Amgen et d'autres	13-08-21

Sector

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-3.39%	102B
REGENERON PHARMACEUTICALS, INC.	+2.61%	96.84B
ARGENX SE	-0.90%	21.48B
BIONTECH SE	-18.14%	20.82B
GENMAB A/S	-7.31%	18.6B
WUXI APPTEC CO., LTD.	-40.70%	16.81B
BEIGENE, LTD.	-26.89%	13.78B
NEUROCRINE BIOSCIENCES, INC.	+1.12%	13.4B
SAREPTA THERAPEUTICS, INC.	+22.25%	11.06B